NINDS Neuroscience Funding Announcements

Basic and Clinical Research on Rett Syndrome and MECP2 (R01)

Funding Contact(s): Laura Mamounas, Ph.D.
Funding Categories: Neurogenetics

Brief Description:
invite research grant applications aimed at understanding and/or treating Rett Syndrome (RTT). The recent demonstration that mutations in the MECP2 gene cause most cases of RTT has created new opportunities for both basic and clinical research. Included within the scope of this Program Announcement with set-aside funds (PAS) are developmental, neuroanatomical, molecular genetic, and pathophysiological research, therapy development projects and clinical studies. Studies of the role of MeCP2 in basic biological processes or in the etiology of other neurological or neurobehavioral disorders are also appropriate.

Grant Mechanism: R01
NIH Guide: PAS-07-192
Release Date: 2006-12-18
Expiration Date: 2007-11-06